Ameritas Investment Partners’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $403K | Buy |
15,711
+391
| +3% | +$10K | 0.01% | 934 |
|
|
2025
Q1 | $421K | Buy |
15,320
+1,147
| +8% | +$31.5K | 0.01% | 895 |
|
|
2024
Q4 | $382K | Buy |
14,173
+1,633
| +13% | +$44K | 0.01% | 956 |
|
|
2024
Q3 | $362K | Buy |
12,540
+500
| +4% | +$14.4K | 0.01% | 975 |
|
|
2024
Q2 | $328K | Buy |
12,040
+840
| +8% | +$22.9K | 0.01% | 971 |
|
|
2024
Q1 | $314K | Buy |
11,200
+587
| +6% | +$16.4K | 0.01% | 1008 |
|
|
2023
Q4 | $282K | Buy |
10,613
+56
| +0.5% | +$1.49K | 0.01% | 1066 |
|
|
2023
Q3 | $270K | Sell |
10,557
-90
| -0.8% | -$2.3K | 0.01% | 1004 |
|
|
2023
Q2 | $279K | Sell |
10,647
-41
| -0.4% | -$1.07K | 0.01% | 954 |
|
|
2023
Q1 | $279K | Buy |
10,688
+58
| +0.5% | +$1.51K | 0.01% | 929 |
|
|
2022
Q4 | $292K | Buy |
10,630
+791
| +8% | +$21.7K | 0.01% | 939 |
|
|
2022
Q3 | $236K | Buy |
+9,839
| New | +$236K | 0.01% | 983 |
|